Literature DB >> 7205981

Leucopenia and thrombocytopenia with cimetidine.

K L Chandrasekhara, S K Iyer, R J Macchia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7205981      PMCID: PMC2552636     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  6 in total

1.  Cimetidine and bone-marrow toxicity.

Authors:  J W Byron
Journal:  Lancet       Date:  1977-09-10       Impact factor: 79.321

2.  Cimetidine and granulocytopenia.

Authors:  J W Freston
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

3.  Agranulocytosis four months after cimetidine therapy.

Authors:  E R Craven; J M Whittington
Journal:  Lancet       Date:  1977-08-06       Impact factor: 79.321

4.  Marrow suppression and intravenous cimetidine.

Authors:  C James; B J Prout
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

5.  Thrombocytopenia with cimetidine therapy.

Authors:  J L McDaniel; J J Stein
Journal:  N Engl J Med       Date:  1979-04-12       Impact factor: 91.245

6.  Association of cimetidine and bone-marrow suppression in man.

Authors:  F Druart; C Frocrain; P Metois; J Martin; C Matuchansky
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

  6 in total
  3 in total

Review 1.  Drug-induced thrombocytopenia in the coronary care unit.

Authors:  N M Patnode; P J Gandhi
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

Review 2.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Lydie Meheus; Vidula Sukhatme; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2014-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.